5. Survival Benefit Roughly 15% of untreated animals died during the 14-day study period, whereas no deaths occurred in any Telomir-1 treated groups - highlighting a systemic survival advantage.

The phase 3 D1AMOND trial (ClinicalTrials.gov Identifier: NCT05615220) evaluated the safety, tolerability, and efficacy of ecopipam in pediatric and adult participants with Tourette syndrome.

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...

Lemierre syndrome was relatively common before the introduction of antibiotics in the 1940s, but is now rare. 1 A prospective study conducted in Denmark from 1998 to 2001 estimated the overall annual ...

About 1 in every 10,000-15,000 girls worldwide are born with Rett syndrome. The disorder is even rarer in boys. RTT is often misdiagnosed, so it could be more common than we think.

Some patients with the Zollinger-Ellison syndrome appear to have hypergastrinaemia and hyperplasia of the antral G cells but no tumour. This subgroup has been classified as Zollinger-Ellison syndrome ...

Usher syndrome is passed on from unaffected parents to their children. It may be inherited when both parents are carriers of an abnormal (harmful) gene. If both parents have a harmful change in the ...

Autoimmune polyendocrine syndrome type 1 (APS-1), also known as autoimmune polyendocrinopathy, candidiasis, and ectodermal dystrophy (APECED), is an autosomal recessive multiorgan syndrome caused ...

Compartment syndrome can be a serious condition that is caused by some kind of trauma, such as a car accident or broken bone. If you have symptoms, you need to see your doctor immediately for ...

This condition affects approximately 1 out of 1 million people worldwide, with symptoms beginning between ages 20 and 50. Treatment can help slow progression and control symptoms, but there is no cure ...